Non-Billable/Non-Specific ICD-10-CM Codes - Page 5

There are 8,831 ICD-10-CM codes which are non-billable/non-specific and can be used to indicate a diagnosis for reimbursement purposes as there are no codes with a greater level of specificity under each code.

  • D31.0 - Benign neoplasm of conjunctiva
  • D31.1 - Benign neoplasm of cornea
  • D31.2 - Benign neoplasm of retina
  • D31.3 - Benign neoplasm of choroid
  • D31.4 - Benign neoplasm of ciliary body
  • D31.5 - Benign neoplasm of lacrimal gland and duct
  • D31.6 - Benign neoplasm of unspecified site of orbit
  • D31.9 - Benign neoplasm of unspecified part of eye
  • D35.0 - Benign neoplasm of adrenal gland
  • D36.1 - Benign neoplasm of peripheral nerves and autonomic nervous system
  • D37.0 - Neoplasm of uncertain behavior of lip, oral cavity and pharynx
  • D37.03 - Neoplasm of uncertain behavior of the major salivary glands
  • D39.1 - Neoplasm of uncertain behavior of ovary
  • D3A.0 - Benign carcinoid tumors
  • D3A.01 - Benign carcinoid tumors of the small intestine
  • D3A.02 - Benign carcinoid tumors of the appendix, large intestine, and rectum
  • D3A.09 - Benign carcinoid tumors of other sites
  • D40.1 - Neoplasm of uncertain behavior of testis
  • D41.0 - Neoplasm of uncertain behavior of kidney
  • D41.1 - Neoplasm of uncertain behavior of renal pelvis
  • D41.2 - Neoplasm of uncertain behavior of ureter
  • D44.1 - Neoplasm of uncertain behavior of adrenal gland
  • D46.2 - Refractory anemia with excess of blasts [RAEB]
  • D47.0 - Mast cell neoplasms of uncertain behavior
  • D47.Z - Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue
  • D48.1 - Neoplasm of uncertain behavior of connective and other soft tissue
  • D48.11 - Desmoid tumor
  • D48.6 - Neoplasm of uncertain behavior of breast
  • D49.5 - Neoplasm of unspecified behavior of other genitourinary organs
  • D49.51 - Neoplasm of unspecified behavior of kidney
  • D49.8 - Neoplasm of unspecified behavior of other specified sites
  • D55.2 - Anemia due to disorders of glycolytic enzymes
  • D57.0 - Hb-SS disease with crisis
  • D57.2 - Sickle-cell/Hb-C disease
  • D57.21 - Sickle-cell/Hb-C disease with crisis
  • D57.4 - Sickle-cell thalassemia
  • D57.41 - Sickle-cell thalassemia, unspecified, with crisis
  • D57.43 - Sickle-cell thalassemia beta zero with crisis
  • D57.45 - Sickle-cell thalassemia beta plus with crisis
  • D57.8 - Other sickle-cell disorders
  • D57.81 - Other sickle-cell disorders with crisis
  • D59.1 - Other autoimmune hemolytic anemias
  • D59.3 - Hemolytic-uremic syndrome
  • D61.0 - Constitutional aplastic anemia
  • D61.8 - Other specified aplastic anemias and other bone marrow failure syndromes
  • D61.81 - Pancytopenia
  • D64.8 - Other specified anemias
  • D68.0 - Von Willebrand disease
  • D68.02 - Von Willebrand disease, type 2
  • D68.3 - Hemorrhagic disorder due to circulating anticoagulants
  • D68.31 - Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
  • D68.5 - Primary thrombophilia
  • D68.6 - Other thrombophilia
  • D69.4 - Other primary thrombocytopenia
  • D69.5 - Secondary thrombocytopenia
  • D72.1 - Eosinophilia
  • D72.11 - Hypereosinophilic syndrome [HES]
  • D72.8 - Other specified disorders of white blood cells
  • D72.81 - Decreased white blood cell count
  • D72.82 - Elevated white blood cell count
  • D73.8 - Other diseases of spleen
  • D75.8 - Other specified diseases of blood and blood-forming organs
  • D75.82 - Heparin induced thrombocytopenia (HIT)
  • D75.83 - Thrombocytosis
  • D78.0 - Intraoperative hemorrhage and hematoma of the spleen complicating a procedure
  • D78.1 - Accidental puncture and laceration of the spleen during a procedure
  • D78.2 - Postprocedural hemorrhage of the spleen following a procedure
  • D78.3 - Postprocedural hematoma and seroma of the spleen following a procedure
  • D78.8 - Other intraoperative and postprocedural complications of the spleen
  • D81.3 - Adenosine deaminase [ADA] deficiency
  • D81.8 - Other combined immunodeficiencies
  • D81.81 - Biotin-dependent carboxylase deficiency
  • D84.8 - Other specified immunodeficiencies
  • D84.82 - Immunodeficiency due to drugs and external causes
  • D86.8 - Sarcoidosis of other sites
  • D89.4 - Mast cell activation syndrome and related disorders
  • D89.8 - Other specified disorders involving the immune mechanism, not elsewhere classified
  • D89.81 - Graft-versus-host disease
  • D89.83 - Cytokine release syndrome
  • E05.0 - Thyrotoxicosis with diffuse goiter
  • E05.1 - Thyrotoxicosis with toxic single thyroid nodule
  • E05.2 - Thyrotoxicosis with toxic multinodular goiter
  • E05.3 - Thyrotoxicosis from ectopic thyroid tissue
  • E05.4 - Thyrotoxicosis factitia
  • E05.8 - Other thyrotoxicosis
  • E05.9 - Thyrotoxicosis, unspecified
  • E07.8 - Other specified disorders of thyroid
  • E08.0 - Diabetes mellitus due to underlying condition with hyperosmolarity
  • E08.1 - Diabetes mellitus due to underlying condition with ketoacidosis
  • E08.2 - Diabetes mellitus due to underlying condition with kidney complications
  • E08.3 - Diabetes mellitus due to underlying condition with ophthalmic complications
  • E08.31 - Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy
  • E08.32 - Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy
  • E08.33 - Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy
  • E08.34 - Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy
  • E08.35 - Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy
  • E08.4 - Diabetes mellitus due to underlying condition with neurological complications
  • E08.5 - Diabetes mellitus due to underlying condition with circulatory complications
  • E08.6 - Diabetes mellitus due to underlying condition with other specified complications
  • E08.61 - Diabetes mellitus due to underlying condition with diabetic arthropathy